期刊文献+

特应性皮炎样小鼠模型皮肤屏障功能受损的分子机制研究 被引量:3

Study on molecular mechanisms of impaired skin barrier function in an atopic dermatitis-like animal model
下载PDF
导出
摘要 目的:建立二硝基氯苯(DNCB)诱导的小鼠AD样模型,观察角质形成细胞的分化和脱落相关基因的表达,探讨皮肤屏障功能受损的分子机制。方法:皮炎组用DNCB两次致敏和两次激发。最后1次致敏后24 h测定各项观察指标。结果:皮炎组小鼠背部经表皮水分丢失量显著高于对照组,角质层含水量显著低于对照组。皮炎组小鼠表皮FLG、IVL、TG-M1荧光强度下降,表皮最外层KLK7荧光强度稍有增强。FLG、IVL、TGM1和KLK7 mRNA的表达出现炎症后修复性改变。结论:DNCB诱导的BALB/c小鼠特应性皮炎样模型存在皮肤屏障功能异常及表皮分化脱落相关基因表达的改变。 Objective: To investigate the molecular mechanisms of impaired skin barrier function in an atopic der- matitis like model of BALB/c mouse induced by 2, 4- dinitrochloro- benzene (DNCB), through theanalysis of gene expression related to epidermal differentiation and degeneration. Methods: Mice in dermatitis group were sensitized twice and challenged twice with DNCB. Data were obtained 24 hours after the second challenge. Results: Mice in dermatitis group has significandy higher TEWL and lower stratum comeum hydration than control group. The protein expression of FIG, IVL and TGM1 in epidermis was decreased in dermatitis group, and the protein expression of KLK7 in the outermost layer of epidermis was increased in dermatitis group. The mRNA expression of FLG, IVL, TGM1 and KLK7 resembled the changes of repair phase after tissue damage. Conclusion: Skin barrier function of atopic dermatitis like model in BALB/c mouse induced by DNCB was impaired, and there is an alteration of the ex- pression of gene related to epidermal differentiation and degeneration.
出处 《中国麻风皮肤病杂志》 2013年第3期164-167,共4页 China Journal of Leprosy and Skin Diseases
基金 中国医师协会皮肤科分会-资生堂DQ基金资助
关键词 表皮屏障 特应性皮炎 动物模型 表皮分化脱落相关基因 skin barrier atopic dermatitis animal model gene related to epidermal differentiation and degener-ation
  • 相关文献

参考文献8

  • 1Kim BE, Leung DY. Epidermal barrier in atopic dermatitis . Aller- gy Asthma Immunol Res,2012,4(1): 12- 16.
  • 2Lee SH, Baek S J, Kim HA, et al. 2, 4 - Dinitrochloro- benzeneinduced atopic dermatitis like immune alteration in mice. J Toxicol Public Health,2006,22(4) : 357 - 364.
  • 3McLean I. Loss- of- function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum come- tun. J Invest Dermatol,2008,128(8) :2117 - 2119.
  • 4Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dys- function in atopie dermatitis. J Invest Dermatol, 2009,129(8) :1892 - 1908.
  • 5Kim BE, Leung DY, Boguniewicz M, et al. Loricrin and involucrin expression is down - regulated by Th2 cytokines through STAT - 6. Clin Immunol, 2008,126(3) : 332 - 337.
  • 6Komatsu N, Saijoh K, Kuk C, et al. Human tissue kallikrein ex- pression in the stratum comeum and serum of atopic dermatitis pa- tients. Exp Dermatol,2007,16(6) :513 - 519.
  • 7Torma H, Lindberg M, Berne B. Skin barrier disruption by sodium lauryl sulfate- exposure alters the expressions of involucrin, trans- glutaminase 1, profilaggrin, and kaUikreins during the repair phase in human skin in vivo. J Invest Dermatol, 2008, 128(5): 1212 - 1219.
  • 8Winge MC, Hoppe T, Berne B, et al. Filaggrin genotype deter- mines functional and molecular alterations in skin of patients with atopic dermatitis and ichthyosis vulgaris. PLoS One, 2011,6( 12): 28254.

同被引文献28

  • 1Li YZ, Lu XY, Jiang W, et al. Anti-inflammatory effect of qingpeng ointment in atopic dermatitis-like murine model [J ]. Evid Based Complement Ahernat Med, 2013, 2013: 907016. DOI: 10.1155/2013/907016.
  • 2Kim BE, Leung DY. Epidermal barrier in atopic dermatitis [ J ]. Allergy Asthma Immunol, Res, 2012, 4 ( 1 ): 12-16. DOI: 10.4168/ aair.2012.4.1.12.
  • 3Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier[Jl. Exp Dermatol, 2008, 17( 12): 1063-1072.
  • 4Weidinger S, Baurecht H, Wagenpfeil S, et al. Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk [J]. J Allergy Clin Immunol, 2008, 122(3): 560-568. DOI: 10.1016/j.jaci.2008.05.050.
  • 5Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis [J 1. J Invest Dermatol, 2009, 129 (8): 1892-1908. DOI: 10.1038/jid.2009.133.
  • 6Kim BE, Leung DY, Boguniewicz M, et al. Loricrin and involuerin expression is down-regulated by Th2 eytokines through STAT-6 [ J ].Clin Immunol, 2008, 126 (3): 332-337. DOI: 10.1016/j.clim. 2007.11.006.
  • 7Komatsu N, Saijoh K, Kuk C, et al. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patientsEJ3. Exp Dermatol, 2007, 16(6): 513-519. DOI: 10.1111/j. 1600-0625.2007.00562.x.
  • 8Sevilla LM, Nachat R, Groot KR, et al. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier[ J ]. J Cell Biol, 2007, 179 (7): 1599-1612. DOI: 10.1083/jcb. 200706187.
  • 9Hansson L, Backman A, Ny A, et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis [J]. J Invest Dermatol, 2002, 118 (3): 444-449. DOI: 10.1046/j.0022-202x.2001.01684.x.
  • 10Buraczewska I, Berne B, Lindberg M, et al. Long-term treatment with moisturizers affects the mRNA levels of genes involved in keratinocyte differentiation and desquamation [Jl. Arch Dermatol Res, 2009, 301 (2): 175 - 181. DOI: 10.1007/s00403-008-0906-6.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部